Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 39 News Items found Feature FDA Approves First Treatment for Patients With All Forms of Histiocytosis Monday, January 30, 2023 Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults. Q&A The Science of Eating Well: MSK Research Focuses on Nutrition after a Stem Cell Transplant Wednesday, March 28, 2018 Learn about how nutrition experts are helping people with cancer maintain a healthy diet both during and after treatment. Translating Science Into Cures: Bringing Fresh Hope to the Denisiuk Family Friday, January 1, 2021 Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK. HPV Vaccine Age Limit: You Might Not Be Too Old — What You Should Know Friday, February 28, 2025 Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer. Polio in NY: What You Should Know Monday, September 12, 2022 Learn what detection of the polio virus in New York State means for you. MSK Nurse Exemplifies Tradition of Filipino Nursing in America Thursday, May 13, 2021 Elaine Mosqueda has traveled far in so many ways since moving from the Philippines to the United States at the age of 21. Support Four Things Parents Should Know about the HPV Vaccine Wednesday, January 27, 2016 Vaccinating children against the human papillomavirus can protect them from developing many types of cancer. Here’s what you need to know. In the Clinic Proton Therapy: A Safer Way to Eliminate Tumors in Kids Tuesday, June 18, 2019 Proton therapy offers a way to treat pediatric cancers more safely. In the Clinic After Isolated Limb Infusion, People with Melanoma Get a Second Chance at Life Wednesday, February 7, 2018 Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Next page Next › Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment